---
$id: https://graph.org.ai/products/commodity/51392208
$type: Product
source: UNSPSC
code: "51392208"
title: "Indanidine"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Indanidine

**UNSPSC Code**: 51392208
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H13N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MP564IFE34, chemically known as 2h-indazol-4-amine, n-(4,5-dihydro-1h-imidazol-2-yl)-2-methyl-, hydrochloride but generally known as indanidine, which bears US NIH Compound Identifier 121924. European Medicines Agency schedules Indanidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08167MIG. The term INDANIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). INDANIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Indanidine under HS 29332990 and SITC 51573. As of Q4 2014, INDANIDINE remains the US FDA Preferred Term for this commodity. Indanidine bears US NLM identifiers UMLS ID C0244275 and NCI Concept Code C65909. SMILES: CN1CC2C(N1)CCCC2NC3=NCCN3.

